• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Getting Fit in 2017

January 9, 2017 By Dr. Jeremy Feldman

Caregiver excercise

Walking is Great Exercise for Patients with Pulmonary Hypertension With the holiday season behind us, many of us have acquired a few pounds that we would like to shed.  January is a great time of the year to embark on a healthy lifestyle.  We will begin a series of articles that focus on this topic. Walk Your Way To Better Health Staying active is a core aspect of a healthy … [Read more...]

Looking Back at 2016 in PAH

December 29, 2016 By Dr. Jeremy Feldman

2016 in PAH Treatments

2016 has been a busy year for PAH.  There was exciting progress and some disappointment as well.  Reata Pharmaceuticals launched their phase 3 study of Bardoxylone Methyl in connective tissue disease related PAH (The CATALYST Study) after showing promising results in their phase 2 study.  Actelion has started their phase 4 study (TRITON) comparing triple vs double up-front … [Read more...]

Update on Affording Your PAH Medications

December 7, 2016 By Dr. Jeremy Feldman

Update on PAH Treatments

There is good news and bad news.  Let’s get the bad news out of the way first.  Good Days announced that they have no further funding available for 2017 for PAH patients.  Now the good news - Caring Voices announced that they will reopen their funding for 2017 beginning Thursday December 8th in the morning.  It is unclear how long they will remain open and how many patients … [Read more...]

Copay, Co-Insurance, Deductibles and Out of Pocket Maximum

December 3, 2016 By Dr. Jeremy Feldman

Insurance Authorizations for PAH

Understanding the basic terminology of your health insurance is vitally important for patients with Pulmonary Hypertension.  As a consumer of health care you need to understand how the system works and the language the insurance company uses to describe their coverage. Deductible A deductible is the amount of money that the patient must pay before their insurance begins to … [Read more...]

Update on Caring Voices for PAH Meds

December 1, 2016 By Dr. Jeremy Feldman

Update on PAH Treatments

We received notification today that Caring Voices has closed their 2017 roster of patients that they are able to help for the time being.  Very little guidance was given about what this means for the remainder of 2017.  There is a possibility that they will reopen their roster and be able to expand the number of PAH patients that they help. Unfortunately this has left … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

PAH research

Exciting New Clinical Trials in PAH

By Dr. Jeremy Feldman

The wheels of progress continue to move forward in PAH research.  Two companies in particular are preparing to

PH TEAM

Is My Pulmonary Hypertension Doctor an Expert?

By Dr. Jeremy Feldman

A 25-year old woman develops slowly progressive shortness of breath.  After two years of wrong turns in her

good news in pah

 

Disclaimer

Recent Blog Posts

  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025
  • In Memoriam:  Greg Ahearn, MD June 16, 2024

Categories

Archives